Packaging Biologic Drugs for Clinical Trials
Contract packaging organizations packaging biologic drugs for clinical trials use technologies that meet the unique requirements of each study.
Contract packaging organizations for clinical trial materials are increasingly handling biologic drugs, which are typically delivered by injection and have more stringent packaging requirements than other drug forms. In addition to the shift to biologics, the trend to direct-to-patient shipping affects how materials are packaged and makes tracking even more important. Careful consideration of primary packaging materials, kit design, and distribution is crucial for optimizing packages that balance user requirements, protection of drug product quality, and efficiency.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the Author
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 44–48
Citation
When referring to this article, please cite it as J. Markarian, “Packaging Biologic Drugs for Clinical Trials" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
